GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,557
Funds Holding Change
+20
Funds Holding Growth
+0.8%
Value
$520B
Holding in Top 10
677
Top 10 Change
+119
Top 10 Growth
+21%
Value Growth
+8%
New
125
Increased
1,064
Reduced
1,183
Closed
79
Capital Inflow
$22.4B
Capital Outflow
$18.1B
Net Capital Flow
+$4.36B
Capital Flow Change
-$2.89B
Calls
$6.94B
Puts
$6.18B
Net Calls
+$760M
Put/Call Ratio
0.89